Lupus Therapeutics, the clinical affiliate of the Lupus Research Alliance (LRA), today announced a pioneering funding mechanism to address one of the most common questions about lupus clinical care and management.
Mirum expands rare disease portfolio with digestive disorder drugs – Pharmaceutical Technology
Mirum Therapeutics acquired two bile disorder drug products from Travere Therapeutics. Credit: peakSTOCK via Getty Images. California-based biotech Mirum Therapeutics has announced the completion of